Multicenter Epidemiological Study for the Evaluation of the Seroprevalence of Total and Neutralizing Antibodies Against Adenoassociated Virus Serotypes Used in Gene Therapy in Patients With Neuromuscular Diseases of Genetic Origin.
Clinical trial NCT07633951 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07633951
- Sponsor
- Genethon
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-12-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.